Excellent 4.6 out of 5
Organophosphate Metabolites

Dimethyldithiophosphate (DMDTP) Environmental Toxin Test

The Dimethyldithiophosphate (DMDTP) Test measures a urinary biomarker of recent exposure to dimethyl organophosphate pesticides. Identifying and reducing exposure may help you avoid acute symptoms (headaches, nausea) and lower the risk of longer-term nervous system and neurodevelopmental effects linked to these pesticides.

With Superpower, you have access to a comprehensive range of biomarker tests.

Test for Dimethyldithiophosphate (DMDTP)
Cancel anytime
HSA/FSA eligible
Results in a week
Physician reviewed

Every result is checked

·
CLIA-certified labs

Federal standard for testing

·
HIPAA compliant

Your data is 100% secure

Key Insights

  • See your current exposure to dimethyldithiophosphate (DMDTP) and how it compares with typical levels.
  • Identify meaningful exposure patterns and potential sources (e.g., recent contact, products, water, air, food).
  • Clarify whether this environmental toxin could be contributing to specific symptom clusters or system stress (e.g., endocrine, neuro, hepatic).
  • Support reproductive planning or pregnancy safety by checking for elevations during sensitive life stages.
  • Track trends over time after changing products, environment, or occupational exposures.
  • If appropriate, inform conversations with your clinician about additional evaluations or targeted reduction strategies.

What is Dimethyldithiophosphate (DMDTP)?

DMDTP is a urinary breakdown product of a group of insecticides called organophosphates. Specifically, it reflects exposure to dimethyl organophosphates used in agricultural pest control. People encounter these chemicals through food residues, air or dust near treated areas, and skin contact during mixing, loading, or application. Most labs measure DMDTP in urine using sensitive mass spectrometry, often alongside related metabolites (DMP, DMTP). Because organophosphates are rapidly processed and cleared, a DMDTP result represents recent exposure, typically over the past 1–3 days, rather than a long-term body burden.

Why it matters: organophosphates act on the nervous system by inhibiting acetylcholinesterase, an enzyme that helps turn off nerve signaling. At high exposure, this causes classic poisoning symptoms; at lower levels, research focuses on subtler effects on neurobehavior, endocrine signaling, oxidative stress, and mitochondrial function. The body absorbs organophosphates through the gut, lungs, and skin, converts them in the liver, and excretes the dialkyl phosphate metabolites in urine. These compounds are not persistent like older organochlorine pesticides, but repeated low-level contact can keep metabolite levels elevated, which is why targeted testing can be informative.

Why Is It Important to Test For DMDTP?

Testing DMDTP connects what’s happening in your environment to how your body is handling it. Organophosphate exposures are often intermittent — a grocery run with lots of fresh produce, a weekend near fields during spray season, or a day helping in a garden with certain pest controls. A measured DMDTP level can help distinguish incidental contact from sustained exposure. That distinction matters when you’re troubleshooting nonspecific issues like frequent headaches, brain fog, sleep disruption, or gut cramping, especially if your work or home setting raises the odds of contact. It’s also useful when life stage magnifies stakes: pregnancy, fertility planning, early childhood, or chronic neurologic conditions where added system stress is unhelpful. Population biomonitoring studies have used urinary organophosphate metabolites for exactly this purpose — to map what’s typical and identify outliers, then look for patterns over time.

Big picture, your environmental toxin results are one piece of the health puzzle. DMDTP trends make the most sense alongside related biomarkers (other organophosphate metabolites, general liver and kidney function markers) and what you know about your week-to-week routines. For example, a one-time bump may simply reflect a recent exposure window, while a persistently higher pattern suggests ongoing contact that merits a closer look. Epidemiologic research links higher prenatal organophosphate biomarker levels with small differences in child attention and cognition, though findings vary and more research is needed. That’s why context and repetition matter more than any single datapoint.

What Insights Will I Get From a Dimethyldithiophosphate (DMDTP) Test?

Labs typically report DMDTP against reference values derived from large population samples. Because DMDTP is a marker of exposure rather than a nutrient, values toward the lower end are generally preferable when achievable. Interpretation is strongest when you know what happened in the few days before your test — meals, locations, and tasks — and when you repeat testing to confirm a pattern. Many labs also provide creatinine-corrected values to account for hydration, since dilute urine can make levels look artificially low and concentrated urine can make them look higher.

Relatively lower values usually indicate limited recent exposure and a lower likelihood of short-term system stress from dimethyl organophosphates. For most healthy adults, that suggests the nervous system and detox pathways are not dealing with a meaningful current load. In pregnancy and early childhood, where developing brains are especially sensitive to neuroactive chemicals, lower exposure markers are generally considered reassuring, though results always need clinical context.

Relatively higher values can signal recent or ongoing contact with dimethyl organophosphate pesticides. That can place extra work on metabolic and clearance pathways in the liver and kidneys and, depending on magnitude and frequency, may nudge neural signaling toward imbalance through acetylcholinesterase inhibition. Some people notice nonspecific symptoms in these windows — headaches, dizziness, irritability, or abdominal cramping — while others feel nothing at all. Because urinary metabolites clear quickly, a single higher value is best confirmed with trend testing and paired with what you know about your exposures. One important caveat: foods can contain “preformed” dialkyl phosphates that are less toxic than the parent pesticides but still show up in urine; this can inflate results without indicating the same biological impact, which is why patterns and context matter.

Ultimately, a DMDTP result is most powerful when combined with other signals: related organophosphate metabolites, general health markers, and your lived environment. Over weeks to months, that combination helps separate transient spikes from persistent exposure and supports smarter, safer choices in partnership with your clinician. Think of it like the way athletes look at workout recovery — not just one heart rate reading, but trends, sleep, and how they actually feel. With DMDTP, the aim is similar: use clear, current data to make level-headed decisions, especially during sensitive life stages or in higher-exposure settings. As with all environmental health testing, results are informative rather than diagnostic, and they’re most actionable when they’re part of a broader, thoughtful plan.

Superpower also tests for

See more diseases

Frequently Asked Questions About

What is a Dimethyldithiophosphate (DMDTP) test?

This test measures urinary dimethyldithiophosphate (DMDTP), a metabolite and exposure marker of dimethyl organophosphate pesticides.

It is used to estimate recent systemic exposure to these pesticides and can indicate potential risk for organophosphate-related effects (e.g., acetylcholinesterase inhibition), but it does not identify the specific parent pesticide or provide an exact absorbed dose.

Should I test for Dimethyldithiophosphate (DMDTP)?

Dimethyldithiophosphate (DMDTP) is a urinary biomarker of exposure to certain organophosphate pesticides, and it matters because organophosphates can cause acute cholinesterase inhibition and have been associated in studies with longer‑term neurodevelopmental, cognitive, reproductive and endocrine effects that could influence healthspan and longevity. Potential sources include agricultural pesticide spray and residues on conventionally grown food, home or structural pest treatments, and occupational contact; plastics are not a typical source for DMDTP. Testing (usually as part of a urinary dialkyl phosphate panel) helps quantify recent exposure, identify likely exposure routes, and guide practical reduction strategies such as dietary shifts, limiting contact with treated areas, and improving workplace controls or personal protective measures, as well as informing clinical follow‑up when indicated.

Who benefits most: agricultural workers and pesticide applicators, people living near treated fields, residents using home pest treatments, individuals with unexplained neurological or developmental symptoms, people concerned about fertility or thyroid/endocrine health, pregnant people or parents worried about child development, and anyone monitoring environmental exposures as part of longevity or detox optimization efforts.

How often should I test for Dimethyldithiophosphate (DMDTP)?

Test once initially to establish a baseline exposure level; if results are elevated, perform periodic follow-up testing (commonly every few months to annually, based on exposure risk and clinical guidance) and re-test after any significant lifestyle or environment changes such as “after changing household products” or “following detoxification efforts.”

What can affect Dimethyldithiophosphate (DMDTP) test results?

Several factors can alter Dimethyldithiophosphate (DMDTP) test results: timing of sample collection (levels vary shortly after exposure versus later), recent exposure from food, air, water, or household/occupational products, individual metabolism (age, genetics, liver/kidney function), hydration status (urine dilution), and the sample type used (urine versus blood, which show different concentrations); certain medications or dietary supplements may also influence readings.

Are there any preparations needed before testing Dimethyldithiophosphate (DMDTP) levels?

No fasting is required for Dimethyldithiophosphate (DMDTP) testing. DMDTP is usually measured in urine; a first‑morning void is often recommended for consistency but you should follow the specific collection instructions from the laboratory or clinician (some tests may instead ask for a spot or 24‑hour urine). If the goal is to measure baseline exposure, avoid known or new pesticide applications or occupational handling immediately before testing when practical, since recent exposures will raise urinary levels.

Before the test, note and report any recent product use or environmental contact that could affect results — for example, household or agricultural pesticide use, gardening, handling treated clothing, proximity to plastic or chemical processes, or recent use of personal care items or other products that might contain organophosphate compounds. Record dates and times of such exposures and give that information to the clinician or lab with the sample.

How accurate is Dimethyldithiophosphate (DMDTP) testing?

Accuracy depends on proper timing of the sample relative to exposure, the laboratory method used (for example validated GC‑ or LC‑mass spectrometry assays yield the most specific and sensitive results), and consistent, correct sample collection and storage—poor timing, non‑validated methods, or inconsistent collection can produce false negatives or variable results.

What happens if my Dimethyldithiophosphate (DMDTP) levels are outside the optimal or reference range?

High DMDTP levels most often mean recent or ongoing exposure to organophosphate pesticides or slower removal of those chemicals from your body. In plain terms, this can come from work, nearby agricultural spraying, contaminated food or household pesticide use, or from individual differences in metabolism or kidney/liver function that slow clearance. Very high levels raise concern for possible pesticide-related symptoms (nausea, headache, dizziness, muscle weakness, or in extreme cases more serious effects) and usually prompt follow-up — repeat testing, checking other pesticide metabolites, looking for exposure sources, and clinical evaluation.

Low or below‑reference DMDTP levels generally indicate little or no recent exposure or effective clearance, but do not rule out past exposure to other pesticides or combined exposures. Any result should be interpreted alongside other toxin measurements, your lifestyle and occupation, clinical signs, and other health markers rather than on its own; your healthcare provider can help determine whether further testing, exposure reduction, or medical follow‑up is needed.

How do I interpret my Dimethyldithiophosphate (DMDTP) test results?

DMDTP is a urinary dialkyl phosphate metabolite that indicates recent exposure (typically days) to dimethyl organophosphate pesticides. A result above your lab’s reference range suggests recent or ongoing exposure but is non‑specific — it does not identify which pesticide, the exposure route, or the exact dose. A result within or below the reference range may indicate no recent exposure or exposure below the assay’s detection limit, but it does not rule out past exposures. Always compare your result to the laboratory’s reference interval and note whether the urine value is creatinine‑ or specific gravity‑adjusted.

Interpretation is best done in context: trends over time are more informative than a single measurement (declining levels suggest reduced exposure or effective interventions; rising levels suggest ongoing or new exposure). Review DMDTP alongside related toxin markers and body‑system indicators — for example other dialkyl phosphate metabolites, liver and kidney function tests, and oxidative‑stress biomarkers — and consider known exposure history (occupation, home pesticide use, dietary sources). Discuss results with your clinician or occupational health specialist to integrate the lab data with symptoms, exposure history, and any needed follow‑up or mitigation steps.

How it works

1

Test your whole body

Get a comprehensive blood draw at one of our 3,000+ partner labs or from the comfort of your own home.

2

An Actionable Plan

Easy to understand results & a clear action plan with tailored recommendations on diet, lifestyle changes, supplements and pharmaceuticals.

3

A Connected Ecosystem

You can book additional diagnostics, buy curated supplements for 20% off & pharmaceuticals within your Superpower dashboard.

Superpower tests more than 
100+ biomarkers & common symptoms

Developed by world-class medical professionals

Supported by the world’s top longevity clinicians and MDs.

Dr Anant Vinjamoori

Superpower Chief Longevity Officer, Harvard MD & MBA

A smiling woman wearing a white coat and stethoscope poses for a portrait.

Dr Leigh Erin Connealy

Clinician & Founder of The Centre for New Medicine

Man in a black medical scrub top smiling at the camera.

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

membership

$17

/month
Billed annually at $199
A smartphone displays health app results, showing biomarker summary, superpower score, and biological age details.
A website displays a list of most ordered products including a ring, vitamin spray, and oil.
A smartphone displays health app results, showing biomarker summary, superpower score, and biological age details.A tablet screen shows a shopping website with three most ordered products: a ring, supplement, and skincare oil.
What could cost you $15,000 is $199

Superpower
Membership

Your membership includes one comprehensive blood draw each year, covering 100+ biomarkers in a single collection
One appointment, one draw for your annual panel.
100+ labs tested per year
A personalized plan that evolves with you
Get your biological age and track your health over a lifetime
$
17
/month
billed annually
Flexible payment options
Four credit card logos: HSA/FSA Eligible, American Express, Visa, and Mastercard.
Start testing
Cancel anytime
HSA/FSA eligible
Results in a week
Pricing may vary for members in New York and New Jersey **

Finally, healthcare that looks at the whole you